mhurhangee/patent-ind-claim-en huggingface dataset:
A method for configuring a process of a medical device for determining a dose of basal insulin to be administered for glycemic control, wherein the dose is stepwise adapted, the method comprising the steps of: defining different dose adjustment profiles for stepwise adapting the dose for titration, wherein each of the different dose adjustment profiles is based at least on a specific initial dose value, a specific time interval for increasing the dose, a specific dose increase step and a specific low blood glucose threshold value, and wherein the different dose adjustment profiles are defined by selecting the specific initial dose value from a predefined set of initial dose values, the specific time interval for increasing the dose from a predefined set of time intervals, the specific dose increase step from a predefined set of dose increase steps and the specific low blood glucose threshold value from a predefined set of low blood glucose threshold values; storing the different dose adjustment profiles; selecting one of the stored different dose adjustment profiles based on specific requirements for stepwise adapting the dose; and personalising the selected dose adjustment profile by defining at least a specific target blood glucose value for a fasting blood glucose value for a specific user. defining different dose adjustment profiles for stepwise adapting the dose for titration, wherein each of the different dose adjustment profiles is based at least on a specific initial dose value, a specific time interval for increasing the dose, a specific dose increase step and a specific low blood glucose threshold value, and wherein the different dose adjustment profiles are defined by selecting the specific initial dose value from a predefined set of initial dose values, the specific time interval for increasing the dose from a predefined set of time intervals, the specific dose increase step from a predefined set of dose increase steps and the specific low blood glucose threshold value from a predefined set of low blood glucose threshold values; storing the different dose adjustment profiles; selecting one of the stored different dose adjustment profiles based on specific requirements for stepwise adapting the dose; and personalising the selected dose adjustment profile by defining at least a specific target blood glucose value for a fasting blood glucose value for a specific user.
A hand sanitization device (10n; 10o) comprising: a housing configured to be mounted on a door comprising a handle , wherein the handle comprises a rose , wherein the housing is configured to be mounted on the door such that an upper housing portion lies above the rose , a lower housing portion lies below the rose , and a narrow housing portion lies adjacent the rose and conforms thereto; a cartridge disposed within the housing, wherein the cartridge contains a sanitizer agent ; an actuatable pump disposed in the housing and operably coupled with the cartridge , wherein actuation of the actuatable pump causes the cartridge to dispense the sanitizer agent to a user's hand; and an actuation mechanism operably coupled to the actuatable pump and movable from a first position to a second position, wherein movement of the actuation mechanism from the first position to the second position actuates the pump . a housing configured to be mounted on a door comprising a handle , wherein the handle comprises a rose , wherein the housing is configured to be mounted on the door such that an upper housing portion lies above the rose , a lower housing portion lies below the rose , and a narrow housing portion lies adjacent the rose and conforms thereto; a cartridge disposed within the housing, wherein the cartridge contains a sanitizer agent ; an actuatable pump disposed in the housing and operably coupled with the cartridge , wherein actuation of the actuatable pump causes the cartridge to dispense the sanitizer agent to a user's hand; and an actuation mechanism operably coupled to the actuatable pump and movable from a first position to a second position, wherein movement of the actuation mechanism from the first position to the second position actuates the pump .
Device for generating random bit sequences, comprising: - an array of P-N junctions operated above the breakdown voltage, configured to thermally generate charge carriers, - at least one Silicon Photo-Multiplier sensor configured to generate a sequence of endogenous random current pulses (S1) as a result of an impact ionization driven self-amplification of the thermally generated charge carriers to which the at least one Silicon Photo-Multiplier sensor is subject; - a data processing unit configured to receive said sequence of endogenous random current pulses (S1) and to determine a random bit sequence (S2) to be provided to an end user (EU), on the basis of said sequence of endogenous random current pulses (S1) received from said at least one Silicon Photo-Multiplier sensor . - an array of P-N junctions operated above the breakdown voltage, configured to thermally generate charge carriers, - at least one Silicon Photo-Multiplier sensor configured to generate a sequence of endogenous random current pulses (S1) as a result of an impact ionization driven self-amplification of the thermally generated charge carriers to which the at least one Silicon Photo-Multiplier sensor is subject; - a data processing unit configured to receive said sequence of endogenous random current pulses (S1) and to determine a random bit sequence (S2) to be provided to an end user (EU), on the basis of said sequence of endogenous random current pulses (S1) received from said at least one Silicon Photo-Multiplier sensor .
A method of post-processing a voice recognition result , said result comprising a start , an end and a plurality of elements distributed between said start and said end , said post-processing method comprising the following steps: i. receiving said result ; ii. isolating an element from said plurality of elements that has not undergone the validation test of step iii.a.; iii. and then, a. if an element has been isolated in step ii., determining whether it is valid by using a validation test, b. otherwise, go directly to step v.; iv. repeating steps ii. and iii.; v. if at least one element has been determined valid in step iii.a, determining a post-processed solution by using at least one element determined to be valid in step iii.a; characterised in that each element isolated in step ii. is selected from said end of the result to said start of the result consecutively and in that step iii.a. further comprises an instruction to go directly to step v. if the element undergoing the validation test of step iii.a is not determined as valid. i. receiving said result ; ii. isolating an element from said plurality of elements that has not undergone the validation test of step iii.a.; iii. and then, a. if an element has been isolated in step ii., determining whether it is valid by using a validation test, b. otherwise, go directly to step v.; a. if an element has been isolated in step ii., determining whether it is valid by using a validation test, b. otherwise, go directly to step v.; iv. repeating steps ii. and iii.; v. if at least one element has been determined valid in step iii.a, determining a post-processed solution by using at least one element determined to be valid in step iii.a;
A visual readiness indicator for a medical device, comprising: an input for a signal indicating a ready-for-use status; a graphic icon indicating a not-ready-for-use status formed on a base layer; and a liquid crystal (LC) shutter overlaying the base layer with the graphic icon, characterized in that the LC shutter has a transparent icon indicating a ready-for-use status, the transparent icon overlaying a portion of the graphic icon; and in that the input is operable to drive a driven portion of the LC shutter surrounding the transparent icon into an opaque state to obscure all the graphic icon but the portion overlaid by the transparent icon. an input for a signal indicating a ready-for-use status; a graphic icon indicating a not-ready-for-use status formed on a base layer; and a liquid crystal (LC) shutter overlaying the base layer with the graphic icon, characterized in that the LC shutter has a transparent icon indicating a ready-for-use status, the transparent icon overlaying a portion of the graphic icon; and in that the input is operable to drive a driven portion of the LC shutter surrounding the transparent icon into an opaque state to obscure all the graphic icon but the portion overlaid by the transparent icon.
A molecule having the following formula wherein: (A) Ar 1 is wherein, R 1 , R 2 , R 3 , R 4 , and R 5 are each independently selected from the group consisting of H and (C 1 -C 4 )haloalkoxy; (B) Het is wherein, R 6 is H; (C) L 1 is selected from the group consisting of and wherein: Q x is O, and R 7 , R 8 , R 9 , and R 10 are each independently selected from the group consisting of H and (C 1 -C 4 )alkyl; (D) Ar 2 is wherein: X 1 is selected from the group consisting of N and CR 13 , and R 11 , R 12 , R 13 , and R 14 are each independently selected from the group consisting of H, F, and Cl; (E) R 15 is H; (F) Q 1 is O; (G) Q 2 is S; (H) R 16 is (K); (I) R 17 is (K); (J) L 2 is wherein, R 20 , R 21 , R 22 , R 23 , and R 24 are each independently selected from the group consisting of H, (C 1 -C 4 )alkyl, and (C 1 -C 4 )alkyl-O-(C 1 -C 4 )alkyl; and (K) R 16 and R 17 along with C x (Q 2 )(N x ), is wherein, R 18 and R 19 are each independently H, and N-oxides, agriculturally acceptable acid addition salts, salt derivatives, solvates, ester derivatives, crystal polymorphs, isotopes, resolved stereoisomers, and tautomers of the molecules of Formula One. (A) Ar 1 is wherein, R 1 , R 2 , R 3 , R 4 , and R 5 are each independently selected from the group consisting of H and (C 1 -C 4 )haloalkoxy; (B) Het is wherein, R 6 is H; (C) L 1 is selected from the group consisting of and wherein: Q x is O, and R 7 , R 8 , R 9 , and R 10 are each independently selected from the group consisting of H and (C 1 -C 4 )alkyl; Q x is O, and R 7 , R 8 , R 9 , and R 10 are each independently selected from the group consisting of H and (C 1 -C 4 )alkyl; (D) Ar 2 is wherein: X 1 is selected from the group consisting of N and CR 13 , and R 11 , R 12 , R 13 , and R 14 are each independently selected from the group consisting of H, F, and Cl; X 1 is selected from the group consisting of N and CR 13 , and R 11 , R 12 , R 13 , and R 14 are each independently selected from the group consisting of H, F, and Cl; (E) R 15 is H; (F) Q 1 is O; (G) Q 2 is S; (H) R 16 is (K); (I) R 17 is (K); (J) L 2 is wherein, R 20 , R 21 , R 22 , R 23 , and R 24 are each independently selected from the group consisting of H, (C 1 -C 4 )alkyl, and (C 1 -C 4 )alkyl-O-(C 1 -C 4 )alkyl; and (K) R 16 and R 17 along with C x (Q 2 )(N x ), is wherein, R 18 and R 19 are each independently H, and N-oxides, agriculturally acceptable acid addition salts, salt derivatives, solvates, ester derivatives, crystal polymorphs, isotopes, resolved stereoisomers, and tautomers of the molecules of Formula One.
A salt of (E)-N-(2-amino-phenyl)-3-{1-[4-(1-methyl-1H-pyrazol-4-yl)-benzenesulfonyl]-1H-pyrrol-3-yl }-acrylamide, wherein the salt is toluenesulfonate.
Device for controlling switching of a transistor , comprising: - said transistor , which comprises a control electrode and power electrodes ; - a control circuit connected to said control electrode ; - means for limiting a time derivative of a power current (i(t)) flowing between said power electrodes , said limiting means automatically controlling a measurement voltage (V L2 ) that is proportional to said time derivative to a preset reference voltage by applying an error voltage to said control electrode , said error voltage being amplified by an intrinsic gain of said transistor in linear mode, said reference voltage being higher than or equal to a threshold voltage of conduction of said transistor , said limiting means comprising a first inductor that is connected to a first electrode of said power electrodes and passed through by said power current (i(t)), that is negatively magnetically coupled (k) to a second inductor , that is inserted in series between said control circuit and said control electrode , and that delivers, across its terminals, said measurement voltage (V L2 ), a limitation of said time derivative being given by the expression Vref/L1, where Vref is said reference voltage and L1 is an inductance value of said first inductor , characterized in that said limiting means (V L2 ) further comprise a DC voltage source having a preset nominal voltage (2×Vd) inserted in series between said control circuit and said second inductor such that said reference voltage is equal to a sum of said threshold voltage and of said nominal voltage (2×Vd). - said transistor , which comprises a control electrode and power electrodes ; - a control circuit connected to said control electrode ; - means for limiting a time derivative of a power current (i(t)) flowing between said power electrodes ,
An ophthalmic injection device comprising: an elongated body with a hollow cannula secured to a distal end of the body; a reservoir for an injection material to be delivered through the cannula ; a plunger with a force element that provides an injection force to the injection material; a valve disposed in the flow path between the reservoir and the cannula; and a valve actuation mechanism for the valve that is external to the valve; wherein the valve actuation mechanism is attached to the elongated body; wherein, in use, the injection force is applied to the injection material when the valve is in the closed position; wherein subsequent actuation of the valve actuation mechanism opens a flow path through the valve; characterised in that progressive actuation of the valve actuation mechanism increases a flow rate of injection. an elongated body with a hollow cannula secured to a distal end of the body; a reservoir for an injection material to be delivered through the cannula ; a plunger with a force element that provides an injection force to the injection material; a valve disposed in the flow path between the reservoir and the cannula; and a valve actuation mechanism for the valve that is external to the valve; wherein the valve actuation mechanism is attached to the elongated body; wherein, in use, the injection force is applied to the injection material when the valve is in the closed position; wherein subsequent actuation of the valve actuation mechanism opens a flow path through the valve; characterised in that progressive actuation of the valve actuation mechanism increases a flow rate of injection.
An obstruction illuminator comprising: - an elongated body having a first end and a second end opposing the first end, the body comprising an inner cavity extending between the first and second end, - an artificial light source attached to the first end of the body and configured to emit light into the cavity towards the second end, - an emission lens , which is: ∘ provided to the second end of the body , ∘ configured to receive light emitted by the artificial light source , and ∘ configured to refract light into a light pattern suitable for warning about the presence of an obstacle, and - an optical condenser element comprising a collimator provided into the inner cavity of the body between the artificial light source and the emission lens , which collimator is configured to ∘ receive light from the artificial light source , ∘ condense the received light, and to ∘ direct the condensed light toward the emission lens , characterized in that the optical condenser element comprises an objective arranged between the collimator and the emission lens and configured to receive the collimated light from the collimator and to direct the light to the emission lens . - an elongated body having a first end and a second end opposing the first end, the body comprising an inner cavity extending between the first and second end, - an artificial light source attached to the first end of the body and configured to emit light into the cavity towards the second end, - an emission lens , which is: ∘ provided to the second end of the body , ∘ configured to receive light emitted by the artificial light source , and ∘ configured to refract light into a light pattern suitable for warning about the presence of an obstacle, and ∘ provided to the second end of the body , ∘ configured to receive light emitted by the artificial light source , and ∘ configured to refract light into a light pattern suitable for warning about the presence of an obstacle, and - an optical condenser element comprising a collimator provided into the inner cavity of the body between the artificial light source and the emission lens , which collimator is configured to ∘ receive light from the artificial light source , ∘ condense the received light, and to ∘ direct the condensed light toward the emission lens , characterized in that the optical condenser element comprises an objective arranged between the collimator and the emission lens and configured to receive the collimated light from the collimator and to direct the light to the emission lens . ∘ receive light from the artificial light source , ∘ condense the received light, and to ∘ direct the condensed light toward the emission lens ,
A process for production of high purity CO, comprising the steps of: providing a first CO 2 gas with a purity above 90% to a device comprising at least one solid oxide electrolysis cells, (SOEC) and comprising a gas separation unit, providing a current to at least one SOEC and producing a second gas comprising CO in said SOEC by means of CO 2 electrolysis, cooling said second gas and providing the cooled gas to an output gas separation unit, and operating said gas separation unit at temperatures between 0°C and 50°C, thereby producing a third output gas comprising CO with a purity above 90%. providing a first CO 2 gas with a purity above 90% to a device comprising at least one solid oxide electrolysis cells, (SOEC) and comprising a gas separation unit, providing a current to at least one SOEC and producing a second gas comprising CO in said SOEC by means of CO 2 electrolysis, cooling said second gas and providing the cooled gas to an output gas separation unit, and operating said gas separation unit at temperatures between 0°C and 50°C, thereby producing a third output gas comprising CO with a purity above 90%.
A method comprising: receiving, at a vocoder, an audio signal sampled at a first sample rate, the audio signal comprising a first high-band signal sub-portion and a second high-band signal sub-portion ; generating, at a low-band encoder of the vocoder, a low-band excitation signal based on a low-band portion of the audio signal; generating, at a high-band encoder of the vocoder, a first baseband signal for modelling said first high-band signal sub-portion, wherein generating the first baseband signal includes performing a spectral flip operation on a nonlinearly transformed version of the low-band excitation signal; and generating, at said high-band encoder, a second baseband signal for modelling said second high-band signal sub-portion, wherein the first sub-portion is distinct from the second sub-portion, characterized in that the second baseband signal is based on the first baseband signal . receiving, at a vocoder, an audio signal sampled at a first sample rate, the audio signal comprising a first high-band signal sub-portion and a second high-band signal sub-portion ; generating, at a low-band encoder of the vocoder, a low-band excitation signal based on a low-band portion of the audio signal; generating, at a high-band encoder of the vocoder, a first baseband signal for modelling said first high-band signal sub-portion, wherein generating the first baseband signal includes performing a spectral flip operation on a nonlinearly transformed version of the low-band excitation signal; and generating, at said high-band encoder, a second baseband signal for modelling said second high-band signal sub-portion, wherein the first sub-portion is distinct from the second sub-portion, characterized in that the second baseband signal is based on the first baseband signal .
A multimode optical fiber comprising: a graded index glass core having a parabolic graded index, the core having a maximum refractive index Δ greater than 0.5% and less than or equal to 1.2%; and an inner cladding surrounding and in contact with the core, the parabolic shape of the core ending at the innermost radius of the cladding, wherein said inner cladding has a refractive index delta greater than -0.05% and less than 0.05% and comprises an inner radius of about 25 microns; and a second cladding comprising a depressed-index annular portion surrounding the inner cladding, said depressed-index annular portion having a refractive index delta less than - 0.4 % relative to an outer annular portion of the cladding; and said depressed-index annular portion has a width greater than 2 microns and less than 10 microns; and characterised in that the core has an alpha value from about 2.1 to 2.3 and the width of said inner cladding is at least 1.2 microns and less than 2.0 microns a graded index glass core having a parabolic graded index, the core having a maximum refractive index Δ greater than 0.5% and less than or equal to 1.2%; and an inner cladding surrounding and in contact with the core, the parabolic shape of the core ending at the innermost radius of the cladding, wherein said inner cladding has a refractive index delta greater than -0.05% and less than 0.05% and comprises an inner radius of about 25 microns; and a second cladding comprising a depressed-index annular portion surrounding the inner cladding, said depressed-index annular portion having a refractive index delta less than - 0.4 % relative to an outer annular portion of the cladding; and said depressed-index annular portion has a width greater than 2 microns and less than 10 microns; and characterised in that the core has an alpha value from about 2.1 to 2.3 and the width of said inner cladding is at least 1.2 microns and less than 2.0 microns